Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Launay

Showing results (171-180 of 305) with videos related to

Pageof 31
Sort By:
Antiviral Therapy|May 29, 2009
Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimenElie Azria, Constance Moutafoff, Thomas Schmitz, et al.
Science Translational Medicine|May 30, 2014
CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetusXiaoming Zhang, Brian Mozeleski, Sebastien Lemoine, et al.
Journal of the International AIDS Society|November 14, 2014
CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppressionDominique Costagliola, Jean-Marc Lacombe, Jade Ghosn, et al.
The Journal of Infectious Diseases|January 16, 2016
Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective StudyLionel Piroth, Odile Launay, Marie-Louise Michel, et al.
JAMA|April 14, 2011
Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trialOdile Launay, Diane van der Vliet, Arielle R Rosenberg, et al.
Annals of Internal Medicine|December 8, 2011
Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trialVassilis Tsatsaris, Catherine Capitant, Thomas Schmitz, et al.
The Journal of Antimicrobial Chemotherapy|April 25, 2009
Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustmentMarion Bouillon-Pichault, Vincent Jullien, Elie Azria, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patientsClotilde Allavena, Virginie Ferré, Cécile Brunet-François, et al.
AIDS Research and Human Retroviruses|November 13, 2008
Short communication: Long-term persistence of vaccine-induced HIV seropositivity among healthy volunteersBenjamin Silbermann, Michel Tod, Corinne Desaint, et al.
Plos One|October 20, 2010
French experience of 2009 A/H1N1v influenza in pregnant womenGrégory Dubar, Elie Azria, Antoine Tesnière, et al.
Pageof 31

Showing results (171-180 of 305) with videos related to

Sort By:
Pageof 31
Antiviral Therapy|May 29, 2009
Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimenElie Azria, Constance Moutafoff, Thomas Schmitz, et al.
Science Translational Medicine|May 30, 2014
CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetusXiaoming Zhang, Brian Mozeleski, Sebastien Lemoine, et al.
Journal of the International AIDS Society|November 14, 2014
CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppressionDominique Costagliola, Jean-Marc Lacombe, Jade Ghosn, et al.
The Journal of Infectious Diseases|January 16, 2016
Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective StudyLionel Piroth, Odile Launay, Marie-Louise Michel, et al.
JAMA|April 14, 2011
Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trialOdile Launay, Diane van der Vliet, Arielle R Rosenberg, et al.
Annals of Internal Medicine|December 8, 2011
Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trialVassilis Tsatsaris, Catherine Capitant, Thomas Schmitz, et al.
The Journal of Antimicrobial Chemotherapy|April 25, 2009
Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustmentMarion Bouillon-Pichault, Vincent Jullien, Elie Azria, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patientsClotilde Allavena, Virginie Ferré, Cécile Brunet-François, et al.
AIDS Research and Human Retroviruses|November 13, 2008
Short communication: Long-term persistence of vaccine-induced HIV seropositivity among healthy volunteersBenjamin Silbermann, Michel Tod, Corinne Desaint, et al.
Plos One|October 20, 2010
French experience of 2009 A/H1N1v influenza in pregnant womenGrégory Dubar, Elie Azria, Antoine Tesnière, et al.
Pageof 31